# EDGAR Filing Document

**Accession Number:** 0001429260
**File Stem:** 0001104659-25-121548
**Filing Date:** 2025-12
**Character Count:** 2648
**Document Hash:** 7061fa001c30bfb479b186a2fc5a07af
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-121548.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001104659-25-121548

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fortress Biotech, Inc.
- **CENTRAL INDEX KEY:** 0001429260
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 205157386
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1111 KANE CONCOURSE
- **STREET 2:** SUITE 301
- **CITY:** BAY HARBOR ISLANDS
- **STATE:** FL
- **ZIP:** 33154
- **BUSINESS PHONE:** 781-652-4500

**MAIL ADDRESS:**
- **STREET 1:** 1111 KANE CONCOURSE
- **STREET 2:** SUITE 301
- **CITY:** BAY HARBOR ISLANDS
- **STATE:** FL
- **ZIP:** 33154

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CORONADO BIOSCIENCES INC
- **DATE OF NAME CHANGE:** 20080310

**Fortress Biotech, Inc.**

**1111 Kane Concourse, Suite 301**

**Bay Harbor Islands, Florida 33154**

***VIA EDGAR***

December 16, 2025

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Tim Buchmiller

---

| | |
|:---|:---|
| **Re:** | **Fortress Biotech, Inc.** |

---

**Registration Statement on Form S-1**

**File No. 333-292154**

**Request for Acceleration of Effective Date**

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Fortress Biotech, Inc. (the "**Company**") hereby requests that the Securities and Exchange Commission (the "**Commission**") accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the "**Registration Statement**") so that the Registration Statement will be declared effective as of 4:00 p.m. Eastern time, on December 17, 2025, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or David S. Wolpa, both of whom are attorneys at the Company's outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration.

Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Wolpa at (704) 916-2375.

Thank you for your assistance in this matter.

---

| |
|:---|
| Very truly yours, |
| **Fortress Biotech, Inc.** |
| /s/ David Jin |
| Name: David Jin |
| Title: Chief Financial Officer |

---

cc (via email): Rakesh Gopalan and David Wolpa, Troutman Pepper Locke LLP